Mark Milton
Impact in
- Immunology top 5%
- Biosimilars and Bioanalytical Methods
- Immunotoxicology and immune responses
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Immunology 11
- Biosimilars and Bioanalytical Methods 7
- Immunotoxicology and immune responses 5
-
- Pharmacogenetics and Drug Metabolism 6
- Co-authors
- Christopher J. Horvath (3 shared papers)Cindy Q. Xia (2 shared papers)Liang-Shang L. Gan (2 shared papers)Frank R. Brennan (3 shared papers)Matthew D. Silva (1 shared paper)Peter J. Worland (1 shared paper)Shenghua Wen (1 shared paper)Sudeep Chandra (1 shared paper)
- Journals
- The AAPS Journal (5 papers)Bioanalysis (3 papers)Regulatory Toxicology and Pharmacology (3 papers)Molecular Therapy — Methods & Clinical Development (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mark Milton
38 papers receiving 1.5k citations
Mark Milton's Hit Papers
Peers
Comparison fields: 5 of 106
- Immunology 313
- Pharmacology 148
- Small Animals 108
- Radiology, Nuclear Medicine and Imaging 195
- Oncology 196
Countries citing papers authored by Mark Milton
This map shows the geographic impact of Mark Milton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Milton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Milton more than expected).
Fields of papers citing papers by Mark Milton
This network shows the impact of papers produced by Mark Milton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Milton. The network helps show where Mark Milton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Milton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The determination and interpretation of the therapeutic index in drug development Hit paper breakdown → | 2012 | 461 |
| 2 | 2004 | 138 | |
| 3 | 2009 | 112 | |
| 4 | 2019 | 78 | |
| 5 | 2007 | 77 | |
| 6 | 1990 | 53 | |
| 7 | 2021 | 52 | |
| 8 | 2009 | 51 | |
| 9 | 2008 | 48 | |
| 10 | 2010 | 47 | |
| 11 | 2022 | 43 | |
| 12 | 2020 | 40 | |
| 13 | 2009 | 39 | |
| 14 | 2021 | 37 | |
| 15 | 1988 | 33 | |
| 16 | 2017 | 33 | |
| 17 | 2012 | 32 | |
| 18 | 2017 | 30 | |
| 19 | 2022 | 29 | |
| 20 | 2023 | 29 |
About Mark Milton
Mark Milton is a scholar working on Immunology, Pharmacology, Small Animals, Genetics and Statistics and Probability, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Biosimilars and Bioanalytical Methods (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Immunotoxicology and immune responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Animal testing and alternatives (4 papers), Statistical Methods in Clinical Trials (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Immunology (313 citations), Pharmacology (148 citations), Small Animals (108 citations), Radiology, Nuclear Medicine and Imaging (195 citations) and Oncology (196 citations). Mark Milton has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Christopher J. Horvath, Cindy Q. Xia, Liang-Shang L. Gan, Frank R. Brennan, Matthew D. Silva, Peter J. Worland, Shenghua Wen, Sudeep Chandra, Peter M. Lloyd and G. Gordon Gibson. Their work appears in journals such as The AAPS Journal, Bioanalysis, Regulatory Toxicology and Pharmacology, Molecular Therapy — Methods & Clinical Development and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.